SCHEMBL9530305

SCHEMBL9530305

CCC(C)n1c(C=O)c(CCC(C)C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c1=O

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 5/20 0.41
AGTR1 P30556 5/20 0.41
GP6 Q9HCN6 1/20 0.38
SLC33A1 O00400 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532545 0.93 AGTR2 (0.43) AGTR2AGTR1GP6SLC33A1
SCHEMBL9534310 0.93 AGTR2 (0.38) AGTR2AGTR1GP6
SCHEMBL9554046 0.92 AGTR1 (0.47) AGTR2AGTR1GP6
SCHEMBL9554351 0.89 AGTR2 (0.40) AGTR2AGTR1GP6
SCHEMBL9530476 0.89 AGTR1 (0.42) AGTR2AGTR1SLC33A1
SCHEMBL9530523 0.89 AGTR1 (0.42) AGTR2AGTR1
SCHEMBL9530941 0.88 AGTR1 (0.41) AGTR2AGTR1
SCHEMBL9036154 0.88 AGTR2 (0.40) AGTR2AGTR1GP6
SCHEMBL9553721 0.88 AGTR1 (0.41) AGTR2AGTR1
SCHEMBL9034829 0.88 AGTR2 (0.40) AGTR2AGTR1GP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed